Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |||
| Drowsiness | postmarketing, 13.3% - 16.8% | 5.54% | x | x | x | x | x | x | x | x | x |
| Dizziness | postmarketing, 6.81% - 7.85% | 1.96% | x | x | x | x | x | x | x | x | x |
| Headache | postmarketing, 3.23% - 4.74% | 1.96% | x | x | x | x | x | x | x | x | x |
| Ataxia | postmarketing | x | x | x | x | x | x | x | x | x | |
| Flushing | postmarketing | x | x | x | x | x | x | x | x | x | |
| Orthostatic hypotension | postmarketing | x | x | x | x | x | x | x | x | x | |
| Irritability | postmarketing | x | x | x | x | x | x | x | x | x | |
| Leukopenia | postmarketing | x | x | x | x | x | x | x | x | x | |
| Nausea | postmarketing | x | x | x | x | x | x | x | x | x | |
| Pancytopenia | postmarketing | x | x | x | x | x | x | x | x | x | |
| Convulsion | postmarketing | x | x | x | x | x | x | x | x | x | |
| Syncope | postmarketing | x | x | x | x | x | x | x | x | x | |
| Tachycardia | postmarketing | x | x | x | x | x | x | x | x | x | |
| Tremor | postmarketing | x | x | x | x | x | x | x | x | x | |
| Vertigo | postmarketing | x | x | x | x | x | x | x | x | x | |
| Vomiting | postmarketing | x | x | x | x | x | x | x | x | x | |
| Agitation | postmarketing | x | x | x | x | x | x | x | x | x | |
| Insomnia | postmarketing | x | x | x | x | x | x | x | x | x | |
| Epigastric discomfort | postmarketing | x | x | x | x | x | x | x | x | ||
| Blood disorder | x | ||||||||||
| Hiccups | x | ||||||||||
| Low back pain | x | x | x | x | x | x | x | x | |||
| Viral infection | x | ||||||||||
| Epigastric distress | x | ||||||||||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Discomfort | x | x | x | x | |||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |